These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2233466)

  • 1. Dangers of immunotherapy for the treatment of asthma in children.
    Phelan PD
    Med J Aust; 1990 Sep; 153(6):367. PubMed ID: 2233466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of asthma caused by house-dust mites with a combination of intal and vaccine adsorbed on tyrosine].
    Sychłowy A; Lukas A; Nowak W; Maruszewski W
    Pediatr Pol; 1979 Nov; 54(11):1295-8. PubMed ID: 117423
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of clinical effects of immunotherapy in childhood asthma.
    Iikura Y; Otuka T; Sakamoto Y; Kimata M; Akasawa A; Uekusa T; Saito H; Sakaguchi N; Koya N; Matsumoto K
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):45-55. PubMed ID: 9383891
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of immunotherapy in bronchial asthma: treatment with extracts of house dust and mite.
    Choovoravech P
    J Med Assoc Thai; 1974 Sep; 57(9):445-9. PubMed ID: 4418497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dangers of immunotherapy for the treatment of asthma in children.
    Clarke PS
    Med J Aust; 1990 Dec 3-17; 153(11-12):744. PubMed ID: 2247014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
    Muñoz-López F; Martín Mateos A; Moreira A; Martínez Marín F
    Allergol Immunopathol (Madr); 1994; 22(3):132-4. PubMed ID: 7976962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Do nasal and conjunctival provocation tests represent a trustworthy parameter for the follow-up of childhood IgE-dependent bronchial asthma?].
    Botey J; Eseverri JL; Marin AM
    Allerg Immunol (Paris); 1996 Feb; 28(2):52-4. PubMed ID: 8703310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Desensitization immunotherapy on patients with mite-positive bronchial asthma using purified mite feces antigen fractions].
    Asaoku Y; Jyo T; Mochiduki N; Kodomari Y; Kuwabara M; Yoshizane T; Shigeta S; Ono K; Tsuboi S; Ootsuka T
    Arerugi; 1995 Jul; 44(7):692-700. PubMed ID: 7575135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyposensitisation to house dust mites.
    Br Med J; 1980 Mar; 280(6214):589-90. PubMed ID: 7370597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of ketotifen in the immunotherapy of atopic asthmatics].
    Haddad G; Pacaud D; Papeix P; Tran Q; Vincent J; Steeg LF
    Allerg Immunol (Paris); 1986 May; 18(5):13-6. PubMed ID: 3453715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma.
    Sánchez Palacios A; Schamann Medina F; Lamas Rua-Figueroa A; Bosch Millares C; Ramos Santos S; García Marrero JA
    Allergol Immunopathol (Madr); 1989; 17(6):323-9. PubMed ID: 2635834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
    Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
    Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy.
    Sanders S
    Practitioner; 1966 Jun; 196(176):811-5. PubMed ID: 5936067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunotherapy in bronchial asthma: is there a controversy?].
    Quadrelli SA; Roncoroni AJ
    Medicina (B Aires); 1994; 54(5 Pt 2):605-8. PubMed ID: 7658993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of allergen specific immunotherapy in adult house-dust-mite-sensitive bronchial asthma: impact on disease severity and medical cost].
    Nagata M; Tabe K; Yamamoto H; Sakamoto Y; Matsuo H
    Arerugi; 1999 Dec; 48(12):1316-21. PubMed ID: 10666919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
    Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
    Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatophagoides farinae-sensitized lymphocytes in asthmatic children as evaluated by interleukin-2 (IL-2) production and acquisition of IL-2 responsiveness].
    Mukoyama T; Baba M; Noma T; Yata J
    Arerugi; 1987 Jul; 36(7):351-7. PubMed ID: 3500694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of oral immunotherapy in bronchial asthma caused by Dermatophagoides pternyssinus].
    Pacor ML; Biasi D; Carletto A; Lunardi C
    Recenti Prog Med; 1995 Dec; 86(12):489-91. PubMed ID: 8588080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.